Condition
PPH
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06646653Phase 3Recruiting
EVE TRIAL , ALMA SYSTAM
NCT06166771Not ApplicableUnknown
Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage
NCT06025916Phase 4RecruitingPrimary
Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial
Showing all 3 trials